Mesoblast Limited (MESO) Q4 2026 Earnings Call Transcript

SA Transcripts 162.03K Followers Follow Mesoblast Limited ( MESO ) Q4 2026 Earnings Call August 26, 2026 6:30 PM EDT Company Participants Silviu Itescu - Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director James O’Brien - Chief Financial Officer Conference Call Participants Edward Tenthoff - Piper Sandler & Co., Research Division Olivia Brayer - Cantor Fitzgerald & Co., Research Division Madeleine Williams - Canaccord Genuity Corp., Research Division John Hester - Bell Potter Securities Limited, Research Division Presentation Operator Hello, and welcome to the Mesoblast financial results for the full year ended June 30, 2026. An announcement and presentation have been lodged with the ASX and are also available on the Home and Investor pages at www.mesoblast.com. [Operator Instructions] As a reminder, this conference call is being recorded. Before we begin, let me remind you that during today's conference call, the company will be making forward-looking statements that represent the company's intentions, expectations or beliefs concerning future events. These forward-looking statements are qualified by important factors set forth in today's announcement and the company's filings with the SEC, which could cause actual results to differ materially from those such forward-looking statements. In addition, any forward-looking statements represent the company's views only as of the date of this webcast and should not be relied upon as representing the company's views of any subsequent date. The company specifically disclaims any obligations to update such statements. With that, I would now like to turn the call over to Dr. Silviu Itescu, Chief Executive of Mesoblast. Please go ahead. Silviu Itescu Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director Thank you, operator. Good morning, good afternoon, and thank you all for joining us on Mesoblast's financial results and operational update for the period ended June 30, 2026. With me are our Chief Financial Officer, Jim O'Brien; Chief Commercial Officer, Marcelo Santoro; and our Head of the